Glucocorticoid up-regulates mimecan expression in corticotroph cells

Molecular and Cellular Endocrinology

Volumn 321, Issue 2, 2010, Pages 239-244

  Ma, Qin Yun ^a   Zuo, Chun Lin ^a   Ma, Jun Hua ^a   Zhang, Xiao Na ^a   Ru, Ying ^a   Li, Ping ^a   Pan, Chun Ming ^a   Liu, Zhi ^a   Cao, Huang Ming ^a   Chen, Ming Dao ^a   Song, Huai Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Corticotroph cells; Glucocorticoid; Mimecan expression; Pituitary

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID; LUCIFERASE; MIFEPRISTONE; MIMECAN; GLYCOPROTEIN; HORMONE ANTAGONIST; MESSENGER RNA; OGN PROTEIN, RAT; SIGNAL PEPTIDE;

ACTH SECRETING CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPOPHYSIS; HYPOPHYSIS CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL LINE; DRUG EFFECTS; METABOLISM;

ANIMALS; CELL LINE; CELLS, CULTURED; CORTICOTROPHS; GLUCOCORTICOIDS; GLYCOPROTEINS; HORMONE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIFEPRISTONE; PROMOTER REGIONS, GENETIC; RATS; RNA, MESSENGER; UP-REGULATION;

EID: 77951259109     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.021     Document Type: Article

References (39)

1. Akita S., Webster J., Ren S.G., Takino H., Said J., Zand O. Human and murine pituitary expression of leukemia inhibitory factor. Journal of Clinical Investigation 1995, 95:1288-1298.
2. Ameye L., Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis,Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002, 12:107R-116R.
3. Chesnokova V., Auernhammer C.J., Melmed S. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamopituitary-adrenal axis stress response. Endocrinology 1998, 139:2209-2216.
4. Engler D., Redei E., Kola I. The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocrine Reviews 1999, 20:460-500.
5. Ericson J., Norlin S., Jessell T.M., Edlund T. Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 1998, 125:1005-1015.
6. Fernández B., Kampmann A., Pipp F., Zimmermann R., Schaper W. Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques. Molecular and Cellular Biochemistry 2003, 246:3-11.
7. Funderburgh J.L., Corpuz L.M., Roth M.R., Funderburgh M.L., Tasheva E.S., Conrad G.W. Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin. Journal of Biological Chemistry 1997, 272:28089-28095.
8. Ge G., Seo N.S., Liang X., Hopkins D.R., Hook M., Greenspan D.S. Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. Journal of Biological Chemistry 2004, 279:41626-41633.
9. Greenspan F.S., Gardner D.G. Basic & Clinical Endocrinology 2001, pp. 111. sixth ed.
10. Hu R.M., Han Z.G., Song H.D., Peng Y.D., Huang Q.H., Ren S.X., Gu Y.J., Huang C.H., Li Y.B., Jiang C.L., Fu G., Zhang Q.H., Gu B.W., Dai M., Mao Y.F., Gao G.F., Rong R., Ye M., Zhou J., Xu S.H., Gu J., Shi J.X., Jin W.R., Zhang C.K., Wu T.M., Huang G.Y., Chen Z., Chen M.D., Chen J.L. Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proceedings of the National Academy of Sciences of The United States of America 2000, 97:9543-9548.
11. Hu S.M., Li F., Yu H.M., Li R.Y., Ma Q.Y., Ye T.J., Lu Z.Y., Chen J.L., Song H.D. The Mimecan Gene Expressed in Human Pituitary and Regulated by Pituitary Transcription Factor-1 as a Marker for Diagnosing Pituitary Tumors. Journal of Clinical Endocrinology and Metabolism 2005, 90:6657-6664.
12. Kampmann A., Fernández B., Deindl E., Kubin T., Pipp F., Eitenmüller I., Hoefer I.E., Schaper W., Zimmermann R. The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis. Molecular and Cellular Biochemistry 2009, 322:15-23.
13. Katahira M., Iwasaki Y., Aoki Y., Oiso Y., Saito H. Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 1998, 139:2414-2422.
14. Kawashima K., Yamakawa K., Takahashi W., Takizawa S., Yin P., Sugiyama N., Kanba S., Arita J. The estrogen-occupied estrogen receptor functions as a negative regulator to inhibit cell proliferation induced by insulin/IGF-1: a cell context-specific antimitogenic action of estradiol on rat lactotrophs in culture. Endocrinology 2002, 143:2750-2758.
15. Kresse H., Schonherr E. Proteoglycans of the extracellular matrix and growth control. Journal of Cellular Physiology 2001, 189:266-274.
16. Kuchenbauer F., Hopfner U., Stalla J., Arzt E., Stalla G.K., Páez-Pereda M. Extracellular matrix components regulate ACTH production and proliferation in corticotroph tumor cells. Molecular and Cellular Endocrinology 2001, 175:141-148.
17. Kuchenbauer F., Theodoropoulou M., Hopfner U., Stalla J., Renner U., Tonn J.C., Low M.J., Arzt E., Stalla G.K., Páez-Pereda M. Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development. Molecular and Cellular Endocrinology 2003, 207:13-20.
18. Li Q.L., Yano H., Ren S.G., Li X., Friedman T.C., Melmed S. Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF. Endocrine 1997, 7:325-330.
19. Long C.J., Roth M.R., Tasheva E.S., Funderburgh M., Smit R., Conrad G.W., Funderburgh J.L. Fibroblast growth factor-2 promotes keratan sulfate proteoglycan expression by keratocytes in vitro. Journal of Biological Chemistry 2000, 275:13918-13923.
20. Lovejoy D.A., Balment R.J. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates. General and Comparative Endocrinology 1999, 115:1-22.
21. Iozzo R.V. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. Journal of Biological Chemistry 1999, 274:18843-18846.
22. Lundblad J.R., Roberts J.L. Regulation of proopiomelano-cortin gene expression in pituitary. Endocrine Reviews 1988, 9:135-158.
23. Madisen L., Neubauer M., Plowman G., Rosen D., Segarini P., Dasch J., Thompson A., Ziman J., Bentz H., Purchio A.F. Molecular cloning of a novel bone-forming compound: osteoind uctive factor. DNA Cellular Biology 1990, 9:303-309.
24. Nicol L., Faure M.O., McNeilly J.R., Fontaine J., Taragnat C., McNeilly A.S. Bone morphogenetic protein-4 interacts with activin and GnRH to modulate gonadotrophin secretion in LbetaT2 onadotrophs. Journal of Endocrinology 2008, 196(3):497-507.
25. Nudi M., Ouimette J.F., Drouin J. Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Molecular Endocrinology 2005, 19:1329-1342.
26. Petretto E., Sarwar R., Grieve I., Lu H., Kumaran M.K., Muckett P.J., Mangion J., Schroen B., Benson M., Punjabi P.P., Prasad S.K., Pennell D.J., Kiesewetter C., Tasheva E.S., Corpuz L.M., Webb M.D., Conrad G.W., Kurtz T.W., Kren V., Fischer J., Hubner N., Pinto Y.M., Pravenec M., Aitman T.J., Cook S.A. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nature Genetics 2008, 40:546-552.
27. Ray D.W., Melmed S. Pituitary Cytokine and Growth Factor Expression and Action. Endocrinology Reviews 1997, 18:206-228.
28. Ray D.W., Ren S.G., Melmed S. Leukemia inhibitory factor (LIF)stimulates proopiom-elanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. Journal of Clinical Investigation 1996, 97:1852-1859.
29. Rivier C., Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 1983, 305:325-327.
30. Shanahan C.M., Cary N.R., Osbourn J.K., Weissberg P.L. Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arteriosclerosis Thrombosis and Vascular Biology 1997, 17:2437-2447.
31. Tasheva E.S., Maki C.G., Conrad A.H., Conrad G.W. Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site. Biochimica Biophysica Acta 2001, 1517:333-338.
32. Tasheva E.S., Koester A., Paulsen A.Q., Garrett A.S., Boyle D.L., Davidson H.J., Song M., Fox N., Conrad G.W. Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Molecular Vision 2002, 8:407-415.
33. Tasheva E.S. Analysis of the promoter region of human mimecan gene. Biochimica Biophysica Acta 2002, 1575:123-129.
34. Tasheva E.S., Ke A., Deng Y., Jun C., Takemoto L.J., Koester A., Conrad G.W. Differentially expressed genes in the lens of mimecan-null mice. Molecular Vision 2004, 17:403-416.
35. Taylor A.D., Christian H.C., Morris J.F., Flower R.J., Buckingham J.C. An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro. Endocrinology 1997, 138:2909-2918.
36. Tierney T., Christian H.C., Morris J.F., Solito E., Buckingham J.C. Evidence from studies on co-cultures of TtT/GF and AtT20 cells that Annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release. Journal of Neuroendocrinology 2003, 15:1134-1143.
37. Ujita M., Shinomura T., Kimata K. Molecular cloning of the mouse osteoglycin-encoding gene. Gene 1995, 158:237-240.
38. Wang Y.H., Ma Y., Lu B.J., Xu E.P., Huang Q., Lai M.D. Differential Expression of Mimecan and Thioredoxin Domain-Containing Protein 5 in Colorectal Adenoma and Cancer:A Proteomic Study. Journal of Experimental Biology and Medical Science 2007, 232:1152-1159.
39. Yano H., Readhead C., Nakashima M., Ren S.G., Melmed S. Pituitarydirected leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development. Molecular Endocrinology 1998, 12:1708-1720.